| 000 | 01612 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518035722.0 | ||
| 264 | 0 | _c20200527 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1521-4141 | ||
| 024 | 7 |
_a10.1002/eji.201848014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKozicky, Lisa K | |
| 245 | 0 | 0 |
_aIntravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _c08 2019 |
||
| 300 |
_a1251-1268 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdoptive Transfer |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aColitis _xchemically induced |
| 650 | 0 | 4 |
_aColon _xmetabolism |
| 650 | 0 | 4 | _aDextran Sulfate |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aInterleukin-10 _xgenetics |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 700 | 1 | _aMenzies, Susan C | |
| 700 | 1 | _aHotte, Naomi | |
| 700 | 1 | _aMadsen, Karen L | |
| 700 | 1 | _aSly, Laura M | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 49 _gno. 8 _gp. 1251-1268 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.201848014 _zAvailable from publisher's website |
| 999 |
_c29656512 _d29656512 |
||